FIA
NPTN

FNY Investment Advisers’s NEOPHOTONICS CORP NPTN Stock Holding History

FNY Investment Advisers’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-62,500
Closed -$518K – 1136
2018
Q3 		$518K Buy
+62,500
New +$475K 0.12% 98

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FNY Investment Advisers's NPTN Position: Q4 2018 in Review

FNY Investment Advisers sold out of NEOPHOTONICS CORP (NPTN) in Q4 2018, closing a stake of 62,500 shares — an estimated $518K sold.

FNY Investment Advisers first reported a position in NPTN in Q3 2018 and held it in 1 quarter. The position peaked at $518K in Q3 2018. 115 funds tracked by Wall St. Rank hold NPTN as of Q4 2018.

  • FNY Investment Advisers reported no remaining NEOPHOTONICS CORP position as of Q4 2018 after selling out during the quarter.
  • FNY Investment Advisers sold 62,500 NEOPHOTONICS CORP shares in Q4 2018, an estimated $518K.
  • FNY Investment Advisers first reported a position in NEOPHOTONICS CORP in Q3 2018 and held it in 1 quarter.
  • FNY Investment Advisers's NEOPHOTONICS CORP position peaked at $518K in Q3 2018.
  • 115 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2018.

Based on FNY Investment Advisers's 13F filing for Q4 2018, filed 22 Jan 2019.